EZH2 could also restrain the anti-tumor effect of macrophages and NK cells by suppressing the chemotaxis ability of tumors by reducing the expression level of CXCL10, CCL2, and other chemokines [32,33]. The gene discussed is CCL2; the disease is neoplasm.